Status:
COMPLETED
Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics
Lead Sponsor:
Vanderbilt University
Conditions:
Age-related Macular Degeneration
Eligibility:
All Genders
18+ years
Brief Summary
Repeated exposure to topical antibiotics may alter the normal bacteria on the eye and in the nose and increase rates of resistance. This study will determine whether repeated short-term exposure to to...
Detailed Description
Introduction The treatment of neovascular age-related macular degeneration (AMD) with anti-vascular endothelial growth therapy (ranibizumab and bevacizumab, Genentech, South San Francisco, CA) requir...
Eligibility Criteria
Inclusion
- age greater than 18 with choroidal neovascularization with planned treatment with intravitreal injections
Exclusion
- Use of topical antibiotics for any reason within 3 months, current use of systemic or topical antibiotics, known allergies to gatifloxacin, moxifloxacin, ofloxacin, and azithromycin
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00831961
Start Date
January 1 2009
Last Update
December 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt Eye Institute
Nashville, Tennessee, United States, 37232